Small-cap stocks: 20% circuits after Q4FY26 results

Why small and midcaps outperformed

Smallcap and midcap stocks climbed on Wednesday, beating broader indices with gains of around 1% each. The move was linked to a mix of strong earnings, a fall in oil prices, and improving market sentiment. Several stocks reacted sharply to quarterly numbers, with select counters showing outsized single-day moves. In the small-cap space, upper circuits and high volumes were seen in names tied to chemicals and niche manufacturing.

The session also showed how stock-specific triggers are driving returns, even as sector performance remains uneven. IT services, specialty chemicals, and pharma were among the areas where investors responded quickly to reported profit and revenue changes. At the same time, parts of the midcap basket saw declines, highlighting that the rally was not uniform.

Apcotex Industries hits 20% upper circuit

On May 7, Apcotex Industries hit a 20% upper circuit after announcing its Q4FY26 results. The stock’s move came with robust activity on the NSE, where volume crossed 2.5 lakh shares. The reported volume was described as the highest single-day volume in six months.

The company also declared its highest dividend since 2019, adding to investor interest. The article did not disclose the dividend amount, but the “since 2019” reference set a clear benchmark for the payout history. With a small-cap stock moving straight to the upper circuit, liquidity and price discovery became limited through the day, which is typical in such events.

Coforge jumps 9% as Q4 profit more than doubles

Coforge was among the key gainers, with shares jumping 9% to trade at Rs 1,271 apiece on NSE. The move followed the company’s Q4FY26 earnings, where net profit more than doubled to Rs 612 crore. Revenue from operations rose 30% year-on-year to Rs 4,450 crore in the quarter.

The combination of profit expansion and strong revenue growth helped place Coforge among the day’s standout movers. The rise also contributed to the broader tone in midcaps, where earnings surprises can quickly influence short-term positioning.

SRF rises over 6% and outlines Odisha investment

SRF shares rallied over 6% after the company reported an 11% year-on-year increase in consolidated net profit to Rs 582 crore for Q4. Alongside results, SRF announced plans to invest Rs 2,300 crore to set up a plant in Odisha.

For chemicals, capex plans are closely tracked because they influence future capacity and product mix. In this case, the market reaction combined both near-term profitability (the Q4 net profit growth) and the medium-term investment roadmap (the Odisha plant).

Wockhardt surges nearly 14% on profit turnaround

Wockhardt shares rallied nearly 14% to trade at Rs 1,745.90 apiece. The stock’s move strengthened the broader market tone, according to the article. Over two days, Wockhardt was up more than 22%.

The move came after the company reported a Q4FY26 net profit of Rs 164 crore, a turnaround from a net loss of Rs 45 crore in the corresponding quarter of the previous financial year. Revenue from operations rose 30% year-on-year to Rs 965 crore.

Other movers and laggards in the midcap basket

The article also listed KEI Industries, Biocon, Lupin, Aurobindo Pharma, Persistent Systems and L&T Finance as rising up to 3% each. On the downside, Hero MotoCorp, Hitachi Energy India, Groww, Suzlon Energy, Lenskart, Oil India and others declined up to 2% to lead losses on the Nifty Midcap 100 index.

This split matters because it shows the day’s performance was driven more by stock-level news and sector positioning than a broad-based surge across all midcaps.

Small-cap pharma under Rs 50: Sudarshan Pharma reacts to Q4

Sudarshan Pharma Industries gained about 4% on May 4, after reporting strong Q4 numbers. The company’s March 2026 quarter net profit increased 44.8% to Rs 10.73 crore from Rs 7.41 crore a year earlier.

On the BSE, Sudarshan Pharma’s share price opened at Rs 31.40 per share and also hit that level as the intraday high. The stock was described as being priced below Rs 50, placing it in a category frequently tracked by retail investors for price momentum and liquidity.

Small-cap tape: index trend and uneven sector performance

The BSE SMALLCAP 250 index rose 0.11% on the day referenced in the article, extending a five-day incremental gain of 0.41%. The write-up characterised this as a subtle uptrend, with limited momentum compared with mid and large caps.

Within smallcaps, moves were uneven. Tata Chemicals was cited as the standout performer, delivering a return of 12.52% over the recent period mentioned. India Cements was described as the weakest link, declining 4.47%.

Penny and microcap action: AVI Polymers and Rathi Steel

AVI Polymers, described as a penny stock, was locked at its 5% upper circuit on April 27, closing at Rs 17.26. The stock’s rally pushed it to a one-month high. In Q4, the company reported revenue of Rs 150.28 crore, up 13.6% quarter-on-quarter from Rs 132.32 crore, while net profit rose to Rs 10.24 crore from Rs 7.01 crore in Q3FY26, a 46.1% increase.

The same report noted sharp volatility in April. The shares fell to Rs 10.61 in early April and later rebounded 64% to Rs 17.26 by the Monday close cited. It also referenced a previous month record high of Rs 29.41, and that in February the stock surged 176%, its biggest monthly gain since November 2025 when it advanced 148%.

Rathi Steel and Power ended 14.87% higher at Rs 17 per share on April 2, with a market capitalisation of Rs 146.82 crore. The stock hit an intraday high of Rs 17.50 and an intraday low of Rs 14.00. The company reported 63.4% year-on-year revenue growth in Q4FY26, and the stock’s ROE was listed at 9.91%. The write-up also noted a 52-week high of Rs 35 per share on March 28, 2025.

Key numbers at a glance

Specialty chemicals context: leaders list and valuation backdrop

The article also provided a “Top 10 Chemical Stocks in India January 2026” table, highlighting valuation and return metrics across large listed chemical names. SRF appeared in that list as well, reinforcing the market’s focus on chemicals during the session.

Separately, it noted the breadth of India’s chemical universe by pointing to Advance Petrochemicals, with a market cap of Rs 16 crore. The same context mentioned that some smallcap specialty chemical stocks have seen sharp corrections over the past year and a half.

Market impact: what the numbers suggest

The day’s moves show that earnings and corporate actions are still the clearest catalysts in the current tape. In a single session, Apcotex moving to a 20% upper circuit on strong volume, and Coforge and Wockhardt posting large percentage gains, helped lift sentiment in smaller names. SRF’s gain, coupled with a Rs 2,300 crore investment plan, highlighted how capex announcements can support price action alongside profit growth.

The broader small-cap index move of 0.11% indicates that while select stocks rallied sharply, the wider basket was more restrained. That pattern matched the report’s observation of uneven sector performance within smallcaps.

Analysis: why this cluster of moves matters

Several of the moves were tied to clear, measurable changes: profit doubling at Coforge, a profit turnaround at Wockhardt, and higher reported net profit at SRF. In smallcaps and penny stocks, price moves were amplified by circuits and thinner liquidity, as seen in Apcotex (20%) and AVI Polymers (5%).

The specialty chemicals context is also important because the article pointed to prior corrections in parts of the space, alongside a snapshot of valuation metrics for large chemical leaders. That mix often leads to differentiated outcomes, where strong quarterly numbers can trigger sharp reratings in select names, while the broader segment remains range-bound.

Conclusion

Wednesday’s session was shaped by stock-specific reactions to Q4FY26 results, with Apcotex hitting a 20% upper circuit and larger gainers such as Coforge, SRF and Wockhardt moving on reported profit and revenue numbers. In smallcaps, the BSE SMALLCAP 250’s modest rise contrasted with sharper single-stock moves, reinforcing that earnings and corporate actions are driving the near-term narrative. Investors are likely to continue tracking upcoming results, capex announcements, and dividend decisions for similar momentum-led moves.